Clinical Trials Directory

Trials / Unknown

UnknownNCT02582710

Impact of an Optimized Formulation of Omega 3 on the Composition of Atheromatous Plaques in Patients Requiring Carotid Endarterectomy

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
96 (estimated)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
30 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Determining whether treatment with an optimized formulation of omega 3 for 6 weeks causes a 40% decrease in the average concentration of total microparticles (MPs) in the atheromatous plaque.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTVASCAZEN6 weeks treatment with an optimized formulation of omega 3 before the carotid endarterectomy
DIETARY_SUPPLEMENTPLACEBO6 weeks treatment with a placebo before the carotid endarterectomy

Timeline

Start date
2015-05-01
Primary completion
2018-02-01
Completion
2018-02-01
First posted
2015-10-21
Last updated
2015-10-21

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02582710. Inclusion in this directory is not an endorsement.

Impact of an Optimized Formulation of Omega 3 on the Composition of Atheromatous Plaques in Patients Requiring Carotid E (NCT02582710) · Clinical Trials Directory